Medication info
Vylowjeong 10/20 Milligrams

Vylowjeong 10/20 Milligrams

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
Biconvex rectangular tablet, white to off-white
Packaging
30 tablets (10 tablets/Alu-Alu) x 3
Approval status
Expired

MFDS item code 201600868 · Approved 2016.02.16

This product's status changed to Expired on 2026.02.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of primary·homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medication is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10 mg to 10/40 mg once daily. The generally recommended starting dose is 10/20 mg once daily. For patients who require less LDL cholesterol reduction, treatment may be started at 10/10 mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medication should be used only in patients who have taken 10/80 mg for 12 months or longer without evidence of muscle toxicity (see Precautions, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily in the evening. This medication is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Use in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medication is not recommended in patients with moderate or severe hepatic impairment (see Precautions, 5. General Precautions, Patients with Abnormal Liver Function). Use in patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [GFR] ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated GFR < 60mL/min/1.73㎡, administer 10/20 mg once daily in the evening. If higher doses are administered to these patients, use caution and monitor them closely (see Precautions, 5. General Precautions). Use in older adults No dose adjustment is necessary in older adults. Concomitant use with other medications (See Precautions, 6. Interactions.) Administer this medication at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients taking this medication concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medication. Patients taking this medication concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medication.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary·homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
  • diabetes
  • hypothyroidism
  • obstructive liver disease
  • chronic renal failure
View approved original text

This medication is used as an adjunct to diet for lowering elevated total cholesterol, LDL cholesterol, ApoB, and triglycerides, and for increasing HDL cholesterol in patients with primary hypercholesterolemia, familial and non-familial hypercholesterolemia, and mixed hyperlipidemia. It is also administered as an adjunct when alternative lipid-lowering therapies are inadequate in patients with homozygous familial hypercholesterolemia. This drug is prescribed for patients who have inadequate response to appropriate diet and non-pharmacological interventions, and the secondary causes of dyslipidemia must be identified and treated. Lipid tests before and after treatment should be performed to determine effective treatment direction based on cholesterol and triglyceride levels. Such treatment plays an important role in lowering the risk of atherosclerotic vascular disease due to hypercholesterolemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medication is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10 mg to 10/40 mg once daily. The generally recommended starting dose is 10/20 mg once daily. For patients who require less LDL cholesterol reduction, treatment may be started at 10/10 mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medication should be used only in patients who have taken 10/80 mg for 12 months or longer without evidence of muscle toxicity (see Precautions, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily in the evening. This medication is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Use in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medication is not recommended in patients with moderate or severe hepatic impairment (see Precautions, 5. General Precautions, Patients with Abnormal Liver Function). Use in patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [GFR] ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated GFR < 60mL/min/1.73㎡, administer 10/20 mg once daily in the evening. If higher doses are administered to these patients, use caution and monitor them closely (see Precautions, 5. General Precautions). Use in older adults No dose adjustment is necessary in older adults. Concomitant use with other medications (See Precautions, 6. Interactions.) Administer this medication at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients taking this medication concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this medication. Patients taking this medication concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medication.

Precautions

This medication can cause serious muscle-related side effects such as myopathy or rhabdomyolysis. The risk of such side effects increases particularly when taken at high doses or in combination with certain drugs. If muscle pain, weakness, or unexplained muscle soreness occurs while taking this medication, you must inform your physician immediately. This medication should not be administered to patients with hypersensitivity to its components, those with active liver disease or persistent liver function abnormalities, and pregnant or breastfeeding women. Additionally, the risk of side effects may increase when combined with certain medications, so you must inform your doctor or pharmacist about any current medications. Due to the potential impact on liver function, liver function tests should be performed regularly before and during treatment. It is not recommended for patients with severely impaired liver function. There is insufficient safety data for this medication in children and adolescents, thus it is advisable to avoid use in patients under 10 years of age. Elderly patients may also be more sensitive to this medication, so caution is required during administration, and immediate consultation with medical personnel is needed if any unusual symptoms occur. While taking this medication, you should avoid consuming grapefruit juice or using certain medications (for example, strong CYP3A4 inhibitors, gemfibrozil, cyclosporine, danazol, some antibiotics, calcium channel blockers, etc.). The risk of myopathy can significantly increase when combined with these drugs. Women who are planning to become pregnant or may become pregnant must consult their doctor before taking this medication and stop taking it immediately upon confirmation of pregnancy. Blood glucose levels may rise while taking this medication, so patients at risk for diabetes should regularly monitor their blood glucose levels. In case of overdose, there is no specific antidote, and symptomatic and supportive treatment will be administered according to the symptoms. It is important to strictly adhere to the dosing regimen and amount specified by your doctor while taking this medication and to consult medical personnel immediately if any unusual symptoms arise.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 101 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated hepatic aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • paresthesia
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reactions with systemic symptoms
  • erythema multiforme
  • weakness
  • cataracts
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • taste disorder
  • extraocular muscle dysfunction
  • facial partial paralysis
  • tremors
  • peripheral neuropathy
  • peripheral nerve palsy
  • psychiatric disorders
  • anxiety
  • sleep disturbances
  • memory impairment
  • forgetfulness
  • amnesia
  • memory disorders
  • confusion
  • interstitial lung disease
  • lupus-like erythema
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • arthritis
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • cholestasis jaundice
  • hepatic fat changes
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • erectile dysfunction
  • ophthalmoplegia
  • anemia
  • elevated aminotransferases
  • increased ALP
  • elevated ɤ-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • increased HbA1c
  • elevated fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • increased serum creatine phosphokinase
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is also important to store it at room temperature between 1 and 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

Biconvex rectangular tablet, white to off-white

Package unit

30 tablets (10 tablets/Alu-Alu) x 3

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.